Search clinical trials for: Arm A Vinorelbine (Navelbine oral) Capecitabine (Xeloda)
Total 125 results
-
University of AarhusPierre Fabre LaboratoriesCompleted
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompletedMetastatic Breast CancerGreece
-
Cancer Research Group - Collaborative Group, Beirut...Unknown
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Brigham and Women's HospitalCompleted
-
University of New MexicoCompletedCancer | BreastUnited States
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
RemeGen Co., Ltd.Recruiting
-
Cyclacel Pharmaceuticals, Inc.CompletedAcute Myeloid LeukemiaUnited States
-
Spanish Breast Cancer Research GroupHoffmann-La RocheTerminated
-
Baylor Research InstituteCompletedMetastatic Breast CancerUnited States
-
Gilead SciencesParexel; Iqvia Pty Ltd; Medidata SolutionsActive, not recruitingMetastatic Breast CancerKorea, Republic of, Taiwan, China
-
Cancer Institute and Hospital, Chinese Academy...Not yet recruitingHuman Epidermal Growth Factor 2 Negative Carcinoma of Breast
-
Guangdong Association of Clinical TrialsTerminatedLung Neoplasm MalignantChina
-
US Oncology ResearchGenentech, Inc.TerminatedBreast Neoplasms | Malignant Tumor of the BreastUnited States
-
Cancer Institute and Hospital, Chinese Academy...Recruiting
-
IRCCS Azienda Ospedaliera Universitaria San Martino...UnknownNon Small Cell Lung CancerItaly
-
Sun Yat-sen UniversityRecruitingBreast Cancer | Refractory Breast CarcinomaChina
-
Centre Oscar LambretNational Cancer Institute, France; Pierre Fabre LaboratoriesCompleted
-
Hellenic Cooperative Oncology GroupUniversity of IoanninaCompletedBreast Cancer | Prostate Cancer | Non Small Cell Lung CancerGreece
-
National Cancer Centre, SingaporeCompletedNon-Small Cell Lung CancerSingapore
-
Zhiyong YuNot yet recruitingPathologic Residual Cancer CellsChina
-
Sun Yat-sen UniversityActive, not recruitingEsophageal Cancer | Esophageal Squamous Cell Carcinoma | Oesophageal CancerChina
-
Merck Sharp & Dohme LLCCompletedMetastatic Triple Negative Breast Cancer
-
Ludwig-Maximilians - University of MunichPierre Fabre LaboratoriesCompletedCarcinoma Breast Stage IVGermany
-
Hellenic Oncology Research GroupUniversity Hospital of CreteCompleted
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
Zhejiang UniversityCompleted
-
James J LeeSanofiWithdrawn
-
National Taiwan University HospitalGlaxoSmithKlineCompletedMetastatic Breast CancerTaiwan
-
ARCAGY/ GINECO GROUPPierre Fabre LaboratoriesTerminated
-
Yanqiao ZhangUnknownMetastatic Colorectal Cancer
-
Assistance Publique Hopitaux De MarseilleUnknown
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
ETOP IBCSG Partners FoundationCompleted
-
Gilead SciencesCompletedBreast CancerUnited States, Canada, Spain, France, Belgium, United Kingdom, Germany
-
Abramson Cancer Center at Penn MedicineRoswell Park Cancer Institute; CARTIRecruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2United States
-
Fudan UniversityTerminatedMetastatic Breast CancerChina
-
iOMEDICO AGRoche Pharma AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis...CompletedMetastatic Breast CancerGermany
-
Guangzhou Institute of Respiratory DiseaseRecruitingNon-small Cell Lung Cancer Stage IIIB/IVChina
-
William Chu, MD, MSc, FRCPCPhilips Medical SystemsCompletedRecurrent Rectal CancerCanada
-
Guangdong Provincial People's HospitalSun Yat-sen University; First Affiliated Hospital, Sun Yat-Sen University; Shantou...RecruitingAdvanced Breast Cancer | HER2-negative Breast CancerChina
-
National Cancer Center, KoreaActive, not recruitingTriple Negative Breast CancerKorea, Republic of
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); Susan G. Komen Breast Cancer FoundationCompleted
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; Huiping Li,M.D., Ph.D.,Peking University Cancer HospitalUnknown
-
Instituto Nacional de Cancer, BrazilCompleted
-
Peking University People's HospitalXijing Hospital; Beijing Friendship Hospital; Peking Union Medical College Hospital and other collaboratorsRecruitingRectal Cancer | Pathological Complete Response | Disease Free SurvivalChina
-
Spanish Breast Cancer Research GroupNovartis Pharmaceuticals; ETOP IBCSG Partners Foundation; Breast International...Active, not recruitingAdvanced Breast CancerSpain, Netherlands, France, Italy, Austria, Switzerland
-
Sun Yat-sen UniversityShenzhen People's Hospital; Sixth Affiliated Hospital, Sun Yat-sen University; Dongguan People's Hospital and other collaboratorsNot yet recruiting2-year Disease-Free SurvivalChina